venetoclax,obinutuzumab,zanubrutinib,ibrutinib
beigene,roche,abbvie,janssen
['rosewood', 'zanubrutinib', 'venetoclax', 'lymphoma', 'lymsm', 'ibru', 'follicular']
pleased to share results of #venetoclax and #ibrutinib in relapsed follicular lymphoma at #17icml. #zanubrutinib rosewood study update also supports use of #btk inhibitor in fl. #lymsm #17icml 
Clinical Director, Lymphoma Program, Fred Hutchinson Cancer Center, University of Washington